Westyn Branch-Elliman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibiotic Prophylaxis | 10 | 2020 | 642 | 4.020 |
Why?
|
Anti-Infective Agents | 8 | 2023 | 981 | 3.270 |
Why?
|
Surgical Wound Infection | 12 | 2021 | 1526 | 2.910 |
Why?
|
Pacemaker, Artificial | 5 | 2020 | 808 | 2.150 |
Why?
|
Infection Control | 10 | 2024 | 982 | 1.810 |
Why?
|
Clostridium Infections | 4 | 2019 | 557 | 1.570 |
Why?
|
Defibrillators, Implantable | 5 | 2022 | 1487 | 1.500 |
Why?
|
Anti-Bacterial Agents | 16 | 2023 | 7403 | 1.450 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 486 | 1.400 |
Why?
|
Vancomycin | 6 | 2020 | 503 | 1.370 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1926 | 1.360 |
Why?
|
Staphylococcal Infections | 7 | 2020 | 1406 | 1.290 |
Why?
|
Pandemics | 15 | 2024 | 8611 | 1.250 |
Why?
|
Ambulatory Surgical Procedures | 4 | 2019 | 465 | 1.120 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2020 | 694 | 1.110 |
Why?
|
Veterans | 9 | 2023 | 2631 | 1.050 |
Why?
|
Veterans Health | 6 | 2024 | 215 | 1.040 |
Why?
|
Cross Infection | 6 | 2023 | 1432 | 0.950 |
Why?
|
Informed Consent | 2 | 2021 | 1003 | 0.950 |
Why?
|
Data Collection | 3 | 2024 | 3322 | 0.930 |
Why?
|
Communicable Diseases | 3 | 2023 | 877 | 0.910 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 273 | 0.870 |
Why?
|
Virus Diseases | 2 | 2022 | 719 | 0.840 |
Why?
|
Hypersensitivity | 2 | 2023 | 1155 | 0.830 |
Why?
|
Mastitis | 2 | 2013 | 43 | 0.830 |
Why?
|
Electronic Health Records | 7 | 2023 | 4761 | 0.780 |
Why?
|
Antiviral Agents | 6 | 2024 | 3056 | 0.770 |
Why?
|
Therapeutic Human Experimentation | 1 | 2021 | 43 | 0.770 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 812 | 0.770 |
Why?
|
Natural Language Processing | 2 | 2023 | 1134 | 0.750 |
Why?
|
Pyuria | 1 | 2020 | 30 | 0.720 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2015 | 278 | 0.720 |
Why?
|
Hospitals, Veterans | 8 | 2022 | 395 | 0.710 |
Why?
|
Quarantine | 1 | 2022 | 176 | 0.690 |
Why?
|
Norovirus | 1 | 2020 | 36 | 0.690 |
Why?
|
United States Department of Veterans Affairs | 7 | 2023 | 907 | 0.660 |
Why?
|
Guideline Adherence | 3 | 2019 | 2215 | 0.660 |
Why?
|
Civil Defense | 1 | 2021 | 115 | 0.650 |
Why?
|
Bacterial Infections | 2 | 2017 | 1401 | 0.640 |
Why?
|
Patient Identification Systems | 1 | 2019 | 75 | 0.640 |
Why?
|
Abscess | 2 | 2013 | 605 | 0.640 |
Why?
|
Gastroenteritis | 1 | 2020 | 236 | 0.600 |
Why?
|
Algorithms | 7 | 2021 | 13961 | 0.600 |
Why?
|
Catheters, Indwelling | 2 | 2017 | 428 | 0.600 |
Why?
|
Population Surveillance | 2 | 2020 | 2606 | 0.570 |
Why?
|
Humans | 98 | 2024 | 758406 | 0.560 |
Why?
|
Sterilization | 1 | 2017 | 130 | 0.540 |
Why?
|
beta-Lactams | 1 | 2017 | 157 | 0.520 |
Why?
|
Documentation | 2 | 2020 | 892 | 0.520 |
Why?
|
Retrospective Studies | 31 | 2023 | 80168 | 0.510 |
Why?
|
Quality Assurance, Health Care | 2 | 2023 | 2167 | 0.500 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.500 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 192 | 0.500 |
Why?
|
Outpatients | 3 | 2023 | 1591 | 0.490 |
Why?
|
Disease Outbreaks | 5 | 2024 | 1755 | 0.490 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 1460 | 0.490 |
Why?
|
Neutropenia | 1 | 2019 | 884 | 0.470 |
Why?
|
Bacteremia | 1 | 2021 | 980 | 0.470 |
Why?
|
Intensive Care Units | 4 | 2018 | 3732 | 0.470 |
Why?
|
Immunocompromised Host | 1 | 2019 | 856 | 0.470 |
Why?
|
Ligation | 1 | 2015 | 448 | 0.460 |
Why?
|
Housekeeping, Hospital | 1 | 2014 | 17 | 0.460 |
Why?
|
Drug Hypersensitivity | 1 | 2023 | 915 | 0.460 |
Why?
|
Environmental Microbiology | 1 | 2014 | 46 | 0.460 |
Why?
|
Office Visits | 1 | 2018 | 596 | 0.460 |
Why?
|
Patients' Rooms | 1 | 2014 | 61 | 0.450 |
Why?
|
Education, Professional | 1 | 2014 | 51 | 0.440 |
Why?
|
Computer Systems | 1 | 2015 | 470 | 0.440 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5484 | 0.430 |
Why?
|
Anti-Inflammatory Agents | 2 | 2023 | 1793 | 0.430 |
Why?
|
Schools | 4 | 2022 | 1482 | 0.430 |
Why?
|
Esophageal and Gastric Varices | 1 | 2015 | 208 | 0.420 |
Why?
|
Hospital Costs | 2 | 2017 | 960 | 0.420 |
Why?
|
Luminescent Measurements | 1 | 2014 | 341 | 0.410 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2015 | 249 | 0.400 |
Why?
|
Hysterectomy | 1 | 2018 | 904 | 0.400 |
Why?
|
Influenza Vaccines | 1 | 2019 | 759 | 0.400 |
Why?
|
Disinfection | 1 | 2014 | 209 | 0.390 |
Why?
|
United States | 25 | 2024 | 72136 | 0.380 |
Why?
|
Drug Contamination | 1 | 2012 | 152 | 0.370 |
Why?
|
Patient Admission | 1 | 2018 | 1372 | 0.370 |
Why?
|
Vaccination | 6 | 2023 | 3355 | 0.360 |
Why?
|
Program Development | 1 | 2017 | 1298 | 0.360 |
Why?
|
Disease Transmission, Infectious | 1 | 2015 | 557 | 0.340 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 344 | 0.340 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1911 | 0.330 |
Why?
|
Postpartum Period | 2 | 2013 | 1167 | 0.330 |
Why?
|
Aged | 26 | 2024 | 168218 | 0.330 |
Why?
|
Feedback | 2 | 2023 | 791 | 0.320 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.310 |
Why?
|
Influenza, Human | 1 | 2019 | 1516 | 0.300 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1110 | 0.300 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 1986 | 0.290 |
Why?
|
Cohort Studies | 11 | 2023 | 41256 | 0.280 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2239 | 0.280 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2618 | 0.280 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1005 | 0.280 |
Why?
|
Workload | 1 | 2013 | 847 | 0.280 |
Why?
|
Dexamethasone | 3 | 2023 | 1927 | 0.280 |
Why?
|
Biomedical Research | 1 | 2021 | 3418 | 0.250 |
Why?
|
Harm Reduction | 2 | 2023 | 145 | 0.250 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 586 | 0.250 |
Why?
|
Quality Improvement | 6 | 2023 | 3806 | 0.250 |
Why?
|
Endoscopy | 1 | 2015 | 1834 | 0.240 |
Why?
|
Research Design | 1 | 2021 | 6157 | 0.240 |
Why?
|
Male | 30 | 2024 | 358747 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3599 | 0.230 |
Why?
|
Middle Aged | 23 | 2023 | 219568 | 0.220 |
Why?
|
Female | 29 | 2024 | 390323 | 0.210 |
Why?
|
Aged, 80 and over | 11 | 2022 | 58683 | 0.200 |
Why?
|
Health Personnel | 3 | 2024 | 3312 | 0.200 |
Why?
|
Radiology, Interventional | 2 | 2023 | 475 | 0.200 |
Why?
|
Drug Users | 1 | 2023 | 134 | 0.200 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5331 | 0.200 |
Why?
|
Sisomicin | 1 | 2021 | 5 | 0.200 |
Why?
|
Hepatitis C | 1 | 2012 | 1579 | 0.200 |
Why?
|
Klebsiella | 1 | 2021 | 52 | 0.190 |
Why?
|
Incidence | 4 | 2022 | 21272 | 0.190 |
Why?
|
Mass Vaccination | 1 | 2022 | 109 | 0.180 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 29 | 0.170 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2751 | 0.170 |
Why?
|
Risk Factors | 10 | 2022 | 73809 | 0.170 |
Why?
|
Paraproteinemias | 1 | 2022 | 246 | 0.170 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2023 | 292 | 0.170 |
Why?
|
Policy | 1 | 2023 | 511 | 0.170 |
Why?
|
Cefazolin | 1 | 2019 | 94 | 0.160 |
Why?
|
Communicable Diseases, Emerging | 2 | 2024 | 150 | 0.160 |
Why?
|
Inappropriate Prescribing | 1 | 2022 | 209 | 0.160 |
Why?
|
Oseltamivir | 1 | 2019 | 75 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 617 | 0.160 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.160 |
Why?
|
Public Policy | 1 | 2023 | 559 | 0.160 |
Why?
|
Substance Abuse, Intravenous | 1 | 2023 | 529 | 0.160 |
Why?
|
Hospitalization | 4 | 2022 | 10652 | 0.160 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7810 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 103 | 0.150 |
Why?
|
Soaps | 1 | 2018 | 29 | 0.150 |
Why?
|
Death | 1 | 2023 | 674 | 0.150 |
Why?
|
Treatment Outcome | 8 | 2023 | 64378 | 0.150 |
Why?
|
Urinalysis | 1 | 2020 | 368 | 0.150 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.150 |
Why?
|
Arthritis | 1 | 2023 | 666 | 0.150 |
Why?
|
Goals | 1 | 2023 | 707 | 0.150 |
Why?
|
RNA, Viral | 2 | 2022 | 2836 | 0.140 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 162 | 0.140 |
Why?
|
Boston | 4 | 2020 | 9304 | 0.140 |
Why?
|
Arthroplasty | 1 | 2019 | 313 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.140 |
Why?
|
Health Policy | 3 | 2024 | 2677 | 0.140 |
Why?
|
Substance-Related Disorders | 2 | 2023 | 4402 | 0.140 |
Why?
|
Electrophysiology | 1 | 2019 | 1263 | 0.140 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2019 | 343 | 0.140 |
Why?
|
Adult | 14 | 2024 | 219935 | 0.140 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
Critical Pathways | 1 | 2020 | 473 | 0.130 |
Why?
|
Microbiological Techniques | 1 | 2017 | 98 | 0.130 |
Why?
|
Candida | 1 | 2017 | 173 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1129 | 0.130 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15399 | 0.130 |
Why?
|
Equipment Contamination | 1 | 2017 | 179 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 938 | 0.130 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 621 | 0.120 |
Why?
|
Probability | 1 | 2020 | 2467 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2017 | 385 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 748 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 363 | 0.120 |
Why?
|
Hospitals | 3 | 2023 | 3887 | 0.110 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 504 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2024 | 22029 | 0.110 |
Why?
|
Oxygen | 2 | 2022 | 4191 | 0.110 |
Why?
|
Carrier State | 1 | 2017 | 525 | 0.110 |
Why?
|
Decision Trees | 1 | 2015 | 504 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1812 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1931 | 0.110 |
Why?
|
Motivation | 1 | 2023 | 1996 | 0.110 |
Why?
|
Diarrhea | 1 | 2019 | 1317 | 0.110 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 293 | 0.100 |
Why?
|
Qualitative Research | 1 | 2023 | 2976 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3891 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1890 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1187 | 0.100 |
Why?
|
Markov Chains | 1 | 2015 | 965 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3142 | 0.100 |
Why?
|
Students | 1 | 2021 | 1734 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 787 | 0.100 |
Why?
|
Drug Combinations | 1 | 2017 | 2020 | 0.090 |
Why?
|
Device Removal | 1 | 2016 | 633 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 825 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 715 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1263 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12096 | 0.090 |
Why?
|
Operating Rooms | 1 | 2017 | 789 | 0.090 |
Why?
|
Triage | 1 | 2017 | 986 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1668 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2457 | 0.090 |
Why?
|
Loneliness | 2 | 2022 | 196 | 0.090 |
Why?
|
New York City | 1 | 2012 | 725 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3131 | 0.080 |
Why?
|
Plasma Cells | 2 | 2023 | 591 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2747 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1436 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2551 | 0.080 |
Why?
|
Occupational Health | 1 | 2015 | 805 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2420 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1721 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2925 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 752 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3755 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2690 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 1327 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13276 | 0.070 |
Why?
|
Pilot Projects | 2 | 2023 | 8553 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2492 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3671 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 12759 | 0.070 |
Why?
|
Time Factors | 3 | 2018 | 39872 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 927 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2432 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12876 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13285 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6493 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12440 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 553 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7980 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1936 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8530 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54137 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2018 | 15637 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8426 | 0.050 |
Why?
|
Breast | 1 | 2011 | 1963 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3765 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9650 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14641 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5649 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7378 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15225 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6439 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5427 | 0.050 |
Why?
|
Pregnancy | 2 | 2013 | 29742 | 0.050 |
Why?
|
Naltrexone | 1 | 2023 | 317 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2015 | 4412 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3245 | 0.040 |
Why?
|
Vascular Patency | 1 | 2023 | 895 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 58808 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2023 | 537 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2019 | 198 | 0.040 |
Why?
|
Disaster Planning | 1 | 2024 | 557 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2018 | 398 | 0.040 |
Why?
|
Anxiety | 2 | 2022 | 4539 | 0.040 |
Why?
|
Child | 2 | 2022 | 79818 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4775 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2023 | 1112 | 0.030 |
Why?
|
Adolescent | 3 | 2021 | 87892 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1542 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2023 | 2676 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25956 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1090 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 932 | 0.030 |
Why?
|
Hepacivirus | 1 | 2002 | 1333 | 0.030 |
Why?
|
Geriatrics | 1 | 2018 | 387 | 0.030 |
Why?
|
Teaching | 1 | 2021 | 1168 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2023 | 1786 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22032 | 0.030 |
Why?
|
Depression | 2 | 2022 | 8057 | 0.030 |
Why?
|
Educational Measurement | 1 | 2018 | 1248 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 26183 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2551 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3846 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9599 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1415 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12262 | 0.020 |
Why?
|
Nose | 1 | 2012 | 519 | 0.020 |
Why?
|
Software | 1 | 2002 | 4415 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3570 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4455 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15651 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3717 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6068 | 0.010 |
Why?
|
Reading Frames | 1 | 2002 | 17 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 2002 | 161 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2002 | 365 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29557 | 0.010 |
Why?
|
Viral Nonstructural Proteins | 1 | 2002 | 223 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 929 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42062 | 0.010 |
Why?
|
Genome, Viral | 1 | 2002 | 658 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2176 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 29915 | 0.010 |
Why?
|
Point Mutation | 1 | 2002 | 1593 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3796 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13447 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3502 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17617 | 0.010 |
Why?
|
Genotype | 1 | 2002 | 12945 | 0.000 |
Why?
|